| CAS NO: | 147059-72-1 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Description: Trovafloxacin (CP-99219) is a broad-spectrum quinolone antibiotic that inhibits DNA supercoiling in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV. It has potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin is also a highly potent, specific and orally bioavailable pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1. References: [1].Giustarini
G, et al. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF-
and LPS-induced p65 nuclear translocation in vivo and in vitro. Toxicol
Appl Pharmacol. 2020 Mar 15;391:114915. [2].Poon IK, et al. Unexpected link between an antibiotic, pannexin channels and apoptosis. Nature. 2014 Mar 20;507(7492):329-34. [3].Gootz
TD, et al. Activity of the new fluoroquinolone trovafloxacin
(CP-99,219) against DNA gyrase and topoisomerase IV mutants of
Streptococcus pneumoniae selected in vitro. Antimicrob Agents Chemother.
1996 Dec;40(12):2691-7. Related CAS #: 147059-75-4 (mesylate) 147059-72-1 (free base)
纯度：≥98%
CAS：147059-72-1
m.cnreagent.com